Last edition
News about Global Pharma
Aterian Investment Partners Acquires Contract Pharmaceuticals
Aterian Investment Partners has announced the acquisition of Contract Pharmaceuticals Ltd. Canada, a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms.
Global Pharma | 07/06/2024 | By Aishwarya | 330
Nucleus RadioPharma Receives Series A Extension Funding from AstraZeneca
Nucleus RadioPharma has closed its Series A extension round with new investor AstraZeneca.
Global Pharma | 06/06/2024 | By Aishwarya | 877
AstraZeneca Completes Acquisition of Fusion
AstraZeneca has completed the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
Global Pharma | 06/06/2024 | By Aishwarya | 740
The result of nearly a decade of research, the late breaking research and ongoing scientific trials mark a breakthrough in antioxidant technology to prevent premature aging. When the skin is exposed to ultraviolet rays, Cyclobutane Pyrimidine Dimers [CPDs] are formed, also known as thymine dimers in the DNA molecule.
Global Pharma | 05/06/2024 | By Manvi | 853
Moon Surgical Gets Second FDA Clearance, Covering its Commercial Maestro Robotic Surgery System
Moon Surgical announced the United States Food and Drug Administration (FDA) clearance for the commercial version of its unique Maestro surgical system.
Global Pharma | 05/06/2024 | By Manvi | 614
Kindeva Expands UK Facilities at Charnwood Campus
Kindeva Drug Delivery has expanded their Loughborough, UK, facilities at the Charnwood Campus Science Innovation and Technology Park.
Global Pharma | 05/06/2024 | By Aishwarya | 755
UltraSight Partners with Mayo Clinic to Advance Next Generation Cardiac Care with AI
UltraSight is collaborating with Mayo Clinic on a new endeavor with the goal of enhancing cardiac care by harnessing the power of AI in point-of-care ultrasound.
Global Pharma | 04/06/2024 | By Manvi | 548
PhoreMost Join Hands with Boehringer Ingelheim
PhoreMost Ltd. has made a multi-project target discovery collaboration with Boehringer Ingelheim.
Global Pharma | 04/06/2024 | By Aishwarya | 601
Rhythm Pharma Presents Patient-Reported Experiences with Hyperphagia at ENDO 2024
Rhythm Pharmaceuticals, Inc. has presented the first patient and caregiver reported experiences from qualitative interviews following the completion of a Phase 2 trial.
Global Pharma | 04/06/2024 | By Aishwarya | 534
Pulsenmore Appoints Len Farris as Chief Commercial Officer
Farris will lead Pulsenmore's global commercial growth, overseeing sales, business development, and partnerships.
Global Pharma | 03/06/2024 | By Manvi | 548
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy